Search results

...  targets cancer cells because they express interleukin-2 receptors. ONTAK ACTION Ontak can also be necessary for treating malignant melanoma, probably the most widespread explanation for death in skin cancer cases. During the stage IV of the cancer, malignant melanoma tumors were already observed to reduce and some even stabilize when administered this drug. Having extended spirit  ...

© Copyright 2010-2014